L-Theanine Decreases Orofacial Dyskinesia Induced by Reserpine in Rats
Reserpine (RES)-induced orofacial dyskinesia (OD) has been used as an animal model for human tardive dyskinesia (TD) for decades, due to its strong pathophysiological association with striatal oxidative stress and neural cytoarchitecture alteration. L-Theanine (LT), one of the major amino acid components in green tea, has potent antioxidative, anti-inflammatory, and neuroprotective effects. In this study, we examined the potential protective effects of LT on RES-induced behavioral and neurochemical dysfunction in rats. RES treatment (1 mg/kg s.c., 3 injections 1 day apart) induced significant increases (p < 0.001) in the frequency of vacuous chewing movements (VCM), tongue protrusion (TP), as well as the duration of facial twitching (FT). LT treatment (100, 300 mg/kg orally for 14 days, starting 10 days before RES injection) was able to prevent most of the RES-induced OD. Moreover, LT treatment reduced the RES-induced lipid peroxidation (LPO) production, increased the antioxidation power and catecholamines in the striatum, and significantly reduced the levels of neuroinflammatory and apoptotic markers. Our results indicated that LT was able to counteract the increased oxidative damage, neurotransmitter deficiency, neuroinflammation, and apoptosis induced by RES, and these results have demonstrated the possible neuroprotective effects of LT against RES-induced OD, including antioxidation, neurochemical deficiency prevention, antineuroinflammation, and antiapoptosis. These findings, therefore, suggest a potential role for LT to have a clinically relevant therapeutic effect in delaying or treating human TD.
KeywordsL-Theanine Orofacial dyskinesia Reserpine Striatum
thiobarbituric acid-reactive substance
tumor necrosis factor α
vacuous chewing movements
vesicular monoamine transporter
The authors thank Persistent BioMed Editing services located in Philadelphia, USA, for their valuable editing and proofreading of the current manuscript.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- Cunha AS, Matheus FC, Moretti M, Sampaio TB, Poli A, Santos DB, Colle D, Cunha MP, Blum-Silva CH, Sandjo LP, Reginatto FH, Rodrigues AL, Farina M, Prediger RD (2016) Agmatine attenuates reserpine-induced oral dyskinesia in mice: role of oxidative stress, nitric oxide and glutamate NMDA receptors. Behav Brain Res 312:64–76CrossRefPubMedGoogle Scholar
- Faria RR, Abílio VC, Grassl C, Chinen CC, Negrão LT, de Castro JP, Fukushiro DF, Rodrigues MS, Gomes PH, Registro S, de Carvalho Rde C, D’Almeida V, Silva RH, Ribeiro Rde A, Frussa-Filho R (2005) Beneficial effects of vitamin C and vitamin E on reserpine-induced oral dyskinesia in rats: critical role of striatal catalase activity. Neuropharmacology 48(7):993–1001CrossRefPubMedGoogle Scholar
- Hanff TC, Furst SJ, Minor TR (2010) Biochemical and anatomical substrates of depression and sickness behavior. J Psychiatry Relat Sci 47(1):64–71Google Scholar
- Huang NY, Kostrzewa RM, Li C, Perry KW, Fuller RW (1997) Persistent spontaneous oral dyskinesias in haloperidol-withdrawn rats neonatally lesioned with 6-hydroxydopamine: absence of an association with the Bmax for [3H]raclopride binding to neostriatal homogenates. J Pharmacol Exp Ther 280(1):268–276PubMedGoogle Scholar
- Kronbauer M, Segat HJ, De David Antoniazzi CT, Roversi K, Roversi K, Pase CS, Barcelos RC, Burger ME (2015) Magnesium supplementation prevents and reverses experimentally induced movement disturbances in rats: biochemical and behavioral parameters. Biol Trace Elem Res 166(2):163–172CrossRefPubMedGoogle Scholar
- Patel BA, Arundell M, Parker KH, Yeoman MS, O’Hare D (2005) Simple and rapid determination of serotonin and catecholamines in biological tissue using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Analyt Technol Biomed Life Sci 818(2):269–276CrossRefPubMedGoogle Scholar
- Pérez-Vargas JE, Zarco N, Vergara P, Shibayama M, Segovia J, Tsutsumi V, Muriel P (2016) l-Theanine prevents carbon tetrachloride-induced liver fibrosis via inhibition of nuclear factor κB and down-regulation of transforming growth factor β and connective tissue growth factor. Hum Exp Toxicol 35(2):135–146CrossRefPubMedGoogle Scholar
- Santos JR, Cunha JA, Dierschnabel AL, Campêlo CL, Leão AH, Silva AF, Engelberth RC, Izídio GS, Cavalcante JS, Abílio VC, Ribeiro AM, Silva RH (2013) Cognitive, motor and tyrosine hydroxylase temporal impairment in a model of parkinsonism induced by reserpine. Behav Brain Res 253:68–77CrossRefPubMedGoogle Scholar
- Selvakumar G, Vijayraja D, Krishnamoorthy D, Manivasagam T (2012) Morin attenuates haloperidol induced tardive dyskinesia and oxidative stress in mice. J Nat Sci Res 8(2):153–165Google Scholar
- Túnez I, Collado JA, Medina FJ, Peña J, Del C, Muñoz M, Jimena I, Franco F, Rueda I, Feijóo M, Muntané J, Montilla P (2006) 17 eta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington’s disease in ovariectomized rats. Neurochem Int 48(5):367–373CrossRefPubMedGoogle Scholar
- Zukhurova M, Prosvirnina M, Daineko A, Simanenkova A, Petrishchev N, Sonin D, Galagudza M, Shamtsyan M, Juneja LR, Vlasov T (2013) L-theanine administration results in neuroprotection and prevents glutamate receptor agonist-mediated injury in the rat model of cerebral ischemia-reperfusion. Phytother Res 27(9):1282–1287CrossRefPubMedGoogle Scholar